Skip to main content

Table 3 The health-related quality of life by the EQ-5D (EuroQol) index and visual analogue scale (VAS) at six months after ICU admission compared to the age- and sex-matched general population

From: Six-month survival and quality of life of intensive care patients with acute kidney injury

 

EQ-5D index

EQ-5D VAS

 

Study patients

General population

Study patients

General population

All study patients (N = 959)

0.690 (0.533-1.00)a

0.845 (0.812-0.882)

73 (59–85)

70 (68–77)

No AKI patients (N = 632)

0.690 (0.533-1.00)a

0.845 (0.812-0.882)

75 (60–87)

70 (68–77)

AKI patients (N = 327)

0.676 (0.520-1.00)a

0.826 (0.812-0.859)

70 (50–83)

69 (68–73)

Stage 1 (N = 148)

0.691 (0.534-1.00)a

0.826 (0.812-0.876)

75 (60–86)

69 (68–76)

Stage 2 (N = 65)

0.631 (0.442-0.795)a

0.826 (0.774-0.859)

69 (50–82)

69 (65–73)

Stage 3 (N = 114)

0.676 (0.486-1.00)a

0.845 (0.826-0.859)

70 (50–80)

70 (68–73)

With RRT (of stage 3) (N = 85)

0.676 (0.482-0.802)a

0.845 (0.819-0.882)

65 (50–80)a

70 (68–77)

Without RRT (of stage 3) (N = 29)

0.676 (0.504-1.00)

0.826 (0.826-0.852)

70 (50–90)

68 (68–73)

  1. aP <0.001, comparison between the study patients and the age- and sex-matched general population.
  2. Values are presented as median (interquartile range, IQR). AKI, acute kidney injury (by the Kidney Disease Improving Global Outcomes, KDIGO criteria); RRT, renal replacement therapy.